How to use the speech recognition tool?
NCT01367444
Phase I/IIa Study of SAR422459 in Patients With Stargardt’s Macular Degeneration
Phase I/IIa Study of SAR422459 in Patients With Stargardt’s Macular Degeneration.
Type: Interventional
Status of the trial: Completed
Orphan Drug Recognition: NA
Inclusion
- Opening Date: 2011-05-15
- Closing Date: 2019-05-15
Criteria
Children: No
Adults: Yes
Funder Type: industry
HCP: Principal investigators
HCP: Other investigators
Within ERN-EYE members
Workgroups
Retinal Rare Eye Diseases (WG1)